146 related articles for article (PubMed ID: 6947115)
1. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
Ray PK; Raychaudhuri S
J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
[TBL] [Abstract][Full Text] [Related]
3. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
[TBL] [Abstract][Full Text] [Related]
4. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
5. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
Nitta K; Tanaka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
[TBL] [Abstract][Full Text] [Related]
6. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma.
Urano M; Kim MS
Cancer Res; 1983 Jul; 43(7):3041-4. PubMed ID: 6850614
[TBL] [Abstract][Full Text] [Related]
8. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
Mokyr MB; Dray S
Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
[TBL] [Abstract][Full Text] [Related]
9. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
Mokyr MB; Hengst JC; Dray S
Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
[TBL] [Abstract][Full Text] [Related]
10. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
Tzai TS; Lin JS; Chow NH
J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
[TBL] [Abstract][Full Text] [Related]
11. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
Urano M; Kim MS; Kahn J; Kenton LA; Li ML
Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
[TBL] [Abstract][Full Text] [Related]
12. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.
Takeichi N; Koga Y; Fujii T; Kobayashi H
Cancer Res; 1985 Feb; 45(2):487-91. PubMed ID: 3871352
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
Culo F; Marić M; Morović-Vergles J
In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
[TBL] [Abstract][Full Text] [Related]
14. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM
Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
[No Abstract] [Full Text] [Related]
15. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
Nomi S; Pellis NR; Kahan BD
J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
17. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice.
Chu AM; Fowler JF
Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905
[TBL] [Abstract][Full Text] [Related]
18. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
Wander RH; Hilgard HR
J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
[TBL] [Abstract][Full Text] [Related]
19. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
